How semaglutide affects heart and muscle mass
Part of Hormones & metabolism clinical trials.
This study looks at how semaglutide (Ozempic or Wegovy) changes heart muscle and body muscle. It may help people with type 2 diabetes or those taking the drug for weight loss understand if their heart is affected.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 80 years old
- You are about to start taking semaglutide for type 2 diabetes or to lose weight
- You have not taken semaglutide for more than 2 weeks yet
- You can safely have an MRI (no metal implants, pacemaker, or severe claustrophobia)
- You can walk without help (no cane, walker, or wheelchair)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses special MRI scans to see how the diabetes medication semaglutide affects muscles and fat. If you are starting semaglutide for type 2 diabetes, this research may help doctors understand how the medicine works.
This study tests whether semaglutide, a medicine that helps control blood sugar and reduce weight, can benefit adults with type 1 diabetes who are overweight. If you qualify, you may receive the drug or a placebo, and the study team will monitor your health closely.
This study looks at how genetics may affect your body’s early response to oral semaglutide, a weight-related diabetes medicine. You may be considered if you are overweight (or overweight with prediabetes) and can safely take part in the research.
This study tests whether a medication called semaglutide (which helps with weight loss) can change the bacteria in your gut, which might play a role in weight regulation. By participating, you may receive a treatment that could help you lose weight while researchers learn more about how it works.
This study looks at how brown fat affects weight loss with the medication semaglutide (Wegovy). If you are starting semaglutide for obesity, this trial may help understand if it will work better for you.
This study tests whether a low dose of semaglutide (a once-weekly injection) can help obese adults without diabetes lose weight. Semaglutide works by reducing appetite and helping your body use food differently.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.